Results of a phase I study of RX-5902: An orally bioavailable inhibitor of phosphorylated P68, targeting solid tumors.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 2554-2554
Author(s):  
S. Gail Eckhardt ◽  
William Larry Gluck ◽  
Martin Gutierrez ◽  
Christine Peterson ◽  
Reza Mazhari ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Orally Bioavailable

scholarly journals A Phase I Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 21 Days Every 28 Days in Pediatric Patients with Solid Tumors

2008 ◽  
Vol 14 (4) ◽  
pp. 1111-1115 ◽  
Author(s):  
Elizabeth Fox ◽  
John M. Maris ◽  
Brigitte C. Widemann ◽  
Wendy Goodspeed ◽  
Anne Goodwin ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Pediatric Patients ◽  
Tubulin Inhibitor ◽  
Orally Bioavailable

Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study

2021 ◽  
Author(s):  
Katrina S. Pedersen ◽  
Patrick M. Grierson ◽  
Joel Picus ◽  
A. Craig Lockhart ◽  
Bruce J. Roth ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Phase I ◽  
Tyrosine Kinase Inhibitor ◽  
Solid Tumors ◽  
Phase I Study ◽  
Kinase Inhibitor

A phase I study of the human monoclonal anti-NRP1 antibody MNRP1685A in patients with advanced solid tumors

2014 ◽  
Vol 32 (4) ◽  
pp. 653-660 ◽  
Author(s):  
Colin D. Weekes ◽  
Muralidhar Beeram ◽  
Anthony W. Tolcher ◽  
Kyriakos P. Papadopoulos ◽  
Lia Gore ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors

scholarly journals A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors

2008 ◽  
Vol 63 (6) ◽  
pp. 1147-1156 ◽  
Author(s):  
William R. Schelman ◽  
Sherry Morgan-Meadows ◽  
Rebecca Marnocha ◽  
Fred Lee ◽  
Jens Eickhoff ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors

23 Phase I study of lurbinectedin (PM01183) administered on days (D) 1 & 8 every 3 weeks (q3wk) in patients (pts) with solid tumors

2014 ◽  
Vol 50 ◽  
pp. 13-14 ◽  
Author(s):  
M.J. Ratain ◽  
L. Gore ◽  
S. Szyldergemajn ◽  
J. Diamond ◽  
D. Geary ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study

scholarly journals Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

2013 ◽  
Vol 32 (2) ◽  
pp. 388-388
Author(s):  
Yu Sunakawa ◽  
Junji Furuse ◽  
Takuji Okusaka ◽  
Masafumi Ikeda ◽  
Fumio Nagashima ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Japanese Patients
Sign in / Sign up

Export Citation Format

Share Document